Long-term outcome after alloanergized haploidentical bone marrow transplantation. (A) Actuarial event-free survival (EFS) in patients aged above and below 18 years. The difference in EFS in pediatric and adult patients was due to an increased incidence of early treatment-related mortality (TRM) in adult patients. (B) P values for panels A and B are for the log-rank test. Cumulative incidence of relapse/progression (competing risk death without relapse/progression) was low at 17% for the whole patient cohort (C), and actuarial overall survival at 10 years was 33% (D).